GlassScriptPhysician profile
Nilesh Vyas
NPI 1104837889
$2,152.91
in general payments reported to CMS, 2019-2025
18 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $704 · 2020: $150 · 2021: $165 · 2022: $72.81 · 2023: $125 · 2024: $435 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,061.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $388.90 | 2019-2025 | Rinvoq |
| Stryker Corporation | $381.03 | 2025 | N/A, Ozark Cervical Plate System |
| Sanofi-Aventis U.S. LLC | $226.99 | 2019-2020 | |
| Medtronic, INC. | $178.75 | 2024-2025 | Unid_pass, Inceptiv |
| Janssen Pharmaceuticals, INC | $159.66 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $159.60 | 2019-2023 | Ingrezza |
| Inari Medical, INC. | $158.78 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Glaxosmithkline, LLC. | $109.72 | 2019-2020 | |
| Amgen INC. | $68.42 | 2024 | Krystexxa |
| Novartis Pharmaceuticals Corporation | $67.11 | 2019 | |
| Exact Sciences Corporation | $58.52 | 2023-2025 | Cologuard Collection Kit |
| Depuy Synthes Sales INC. | $39.97 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $29.56 | 2019-2020 | |
| Lilly USA, LLC | $26.62 | 2020-2022 | |
| Allergan, INC. | $26.38 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $25.87 | 2024 | |
| Dexcom, INC. | $24.39 | 2024 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $22.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nilesh Vyas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.